{"id":184634,"date":"2018-01-22T00:00:00","date_gmt":"2018-01-21T23:00:00","guid":{"rendered":"https:\/\/www.bcfi.be\/probiotica-op-basis-van-saccharomyces-boulardii-het-geneesmiddel-enterol-en-diverse-voedingssupplementen-nu-gecontra-indiceerd-bij-ernstig-zieke-patienten-en-patienten-met-immunodepressie-3\/"},"modified":"2018-01-22T00:00:00","modified_gmt":"2018-01-21T23:00:00","slug":"probiotica-op-basis-van-saccharomyces-boulardii-het-geneesmiddel-enterol-en-diverse-voedingssupplementen-nu-gecontra-indiceerd-bij-ernstig-zieke-patienten-en-patienten-met-immunodepressie-3","status":"publish","type":"post","link":"https:\/\/h.cbip.be\/fr\/probiotica-op-basis-van-saccharomyces-boulardii-het-geneesmiddel-enterol-en-diverse-voedingssupplementen-nu-gecontra-indiceerd-bij-ernstig-zieke-patienten-en-patienten-met-immunodepressie-3\/","title":{"rendered":"Probiotica op basis van Saccharomyces boulardii (het geneesmiddel Enterol\u00ae en diverse voedingssupplementen): nu gecontra-indiceerd bij ernstig zieke pati\u00ebnten en pati\u00ebnten met immunodepressie"},"content":{"rendered":"<p>Probiotica op basis van <em>Saccharomyces boulardii<\/em> (het geneesmiddel Enterol\u00ae en diverse voedingssupplementen) zijn voortaan gecontra-indiceerd bij kritisch zieke pati\u00ebnten en bij pati\u00ebnten met immunodepressie. Deze nieuwe contra-indicatie komt er na analyse op Europees niveau van rapporten van systemische infectie met <em>S. boulardii<\/em> bij dergelijke pati\u00ebnten&#x002C; met soms levensbedreigende fungemie. De nieuwe contra-indicatie is breder dan wat op dit ogenblik vermeld wordt in de SKP van Enterol\u00ae (contra-indicatie enkel bij pati\u00ebnten met centrale veneuze katheter).<\/p>\n<p>Lees meer via \u00a0<a href=&quot;https:\/\/www.fagg-afmps.be\/nl\/news\/flash_vig_news_saccharomyces_boulardii_in_belgie_enterolr_risico_van_fungemie_en_contra&quot;>www.fagg-afmps.be\/nl\/news\/flash_vig_news_saccharomyces_boulardii_in_belgie_enterolr_risico_van_fungemie_en_contra<\/a> en <a href=&quot;https:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/Minutes\/2017\/11\/WC500239285.pdf&quot;>www.ema.europa.eu\/docs\/en_GB\/document_library\/Minutes\/2017\/11\/WC500239285.pdf<\/a> (zoekterm \u201cSaccharomyces\u201d).<\/p>\n<p> \u00a0<br \/> \u00a0<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Probiotica op basis van Saccharomyces boulardii (het geneesmiddel Enterol\u00ae en  [&#8230;]<\/p>\n","protected":false},"author":9,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[12,63],"tags":[20213],"class_list":["post-184634","post","type-post","status-publish","format-standard","hentry","category-actualites","category-2018-fr","tag-import_tags"],"_links":{"self":[{"href":"https:\/\/h.cbip.be\/fr\/wp-json\/wp\/v2\/posts\/184634","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/h.cbip.be\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/h.cbip.be\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/h.cbip.be\/fr\/wp-json\/wp\/v2\/users\/9"}],"replies":[{"embeddable":true,"href":"https:\/\/h.cbip.be\/fr\/wp-json\/wp\/v2\/comments?post=184634"}],"version-history":[{"count":0,"href":"https:\/\/h.cbip.be\/fr\/wp-json\/wp\/v2\/posts\/184634\/revisions"}],"wp:attachment":[{"href":"https:\/\/h.cbip.be\/fr\/wp-json\/wp\/v2\/media?parent=184634"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/h.cbip.be\/fr\/wp-json\/wp\/v2\/categories?post=184634"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/h.cbip.be\/fr\/wp-json\/wp\/v2\/tags?post=184634"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}